FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2109928541> ?p ?o ?g. }

• W2109928541 endingPage "R83" @default.
• W2109928541 startingPage "R83" @default.
• W2109928541 abstract "The development of resistance by bacterial species is a compelling issue to reconsider indications and administration of antibiotic treatment. Adequate indications and duration of therapy are particularly important for the use of highly potent substances in the intensive care setting. Until recently, no laboratory marker has been available to differentiate bacterial infection from viral or non-infectious inflammatory reaction; however, over the past years, procalcitonin (PCT) is the first among a large array of inflammatory variables that offers this possibility. The present study aimed to investigate the clinical usefulness of PCT for guiding antibiotic therapy in surgical intensive care patients. All patients requiring antibiotic therapy based on confirmed or highly suspected bacterial infections and at least two concomitant systemic inflammatory response syndrome criteria were eligible. Patients were randomly assigned to either a PCT-guided (study group) or a standard (control group) antibiotic regimen. Antibiotic therapy in the PCT-guided group was discontinued, if clinical signs and symptoms of infection improved and PCT decreased to <1 ng/ml or the PCT value was >1 ng/ml, but had dropped to 25 to 35% of the initial value over three days. In the control group antibiotic treatment was applied as standard regimen over eight days. A total of 110 surgical intensive care patients receiving antibiotic therapy after confirmed or high-grade suspected infections were enrolled in this study. In 57 patients antibiotic therapy was guided by daily PCT and clinical assessment and adjusted accordingly. The control group comprised 53 patients with a standardized duration of antibiotic therapy over eight days. Demographic and clinical data were comparable in both groups. However, in the PCT group the duration of antibiotic therapy was significantly shorter than compared to controls (5.9 +/- 1.7 versus 7.9 +/- 0.5 days, P < 0.001) without negative effects on clinical outcome. Monitoring of PCT is a helpful tool for guiding antibiotic treatment in surgical intensive care patients. This may contribute to an optimized antibiotic regimen with beneficial effects on microbial resistance and costs in intensive care medicine. Results were previously published in German in Anaesthesist 2008; 57: 571–577 (PMID: 18463831). ISRCTN10288268" @default.
• W2109928541 created "2016-06-24" @default.
• W2109928541 creator A5004207218 @default.
• W2109928541 creator A5005130667 @default.
• W2109928541 creator A5015782926 @default.
• W2109928541 creator A5025632181 @default.
• W2109928541 creator A5036649021 @default.
• W2109928541 creator A5048394541 @default.
• W2109928541 creator A5084341919 @default.
• W2109928541 date "2009-01-01" @default.
• W2109928541 modified "2023-10-17" @default.
• W2109928541 title "Procalcitonin to guide duration of antibiotic therapy in intensive care patients: a randomized prospective controlled trial" @default.
• W2109928541 cites W138966464 @default.
• W2109928541 cites W1497832467 @default.
• W2109928541 cites W1550313421 @default.
• W2109928541 cites W1567584890 @default.
• W2109928541 cites W1888492503 @default.
• W2109928541 cites W1898928487 @default.
• W2109928541 cites W1970057865 @default.
• W2109928541 cites W1992795394 @default.
• W2109928541 cites W1993397663 @default.
• W2109928541 cites W2006239039 @default.
• W2109928541 cites W2023722505 @default.
• W2109928541 cites W2026649815 @default.
• W2109928541 cites W2050421202 @default.
• W2109928541 cites W2078068158 @default.
• W2109928541 cites W2079215889 @default.
• W2109928541 cites W2100154890 @default.
• W2109928541 cites W2110521392 @default.
• W2109928541 cites W2125699736 @default.
• W2109928541 cites W2152955526 @default.
• W2109928541 cites W2156803121 @default.
• W2109928541 cites W2158000594 @default.
• W2109928541 cites W2324806916 @default.
• W2109928541 cites W2403536924 @default.
• W2109928541 cites W2486275519 @default.
• W2109928541 cites W2599527603 @default.
• W2109928541 cites W2724250638 @default.
• W2109928541 cites W2768146862 @default.
• W2109928541 doi "https://doi.org/10.1186/cc7903" @default.
• W2109928541 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2717450" @default.
• W2109928541 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19493352" @default.
• W2109928541 hasPublicationYear "2009" @default.
• W2109928541 type Work @default.
• W2109928541 sameAs 2109928541 @default.
• W2109928541 citedByCount "264" @default.
• W2109928541 countsByYear W21099285412012 @default.
• W2109928541 countsByYear W21099285412013 @default.
• W2109928541 countsByYear W21099285412014 @default.
• W2109928541 countsByYear W21099285412015 @default.
• W2109928541 countsByYear W21099285412016 @default.
• W2109928541 countsByYear W21099285412017 @default.
• W2109928541 countsByYear W21099285412018 @default.
• W2109928541 countsByYear W21099285412019 @default.
• W2109928541 countsByYear W21099285412020 @default.
• W2109928541 countsByYear W21099285412021 @default.
• W2109928541 countsByYear W21099285412022 @default.
• W2109928541 countsByYear W21099285412023 @default.
• W2109928541 crossrefType "journal-article" @default.
• W2109928541 hasAuthorship W2109928541A5004207218 @default.
• W2109928541 hasAuthorship W2109928541A5005130667 @default.
• W2109928541 hasAuthorship W2109928541A5015782926 @default.
• W2109928541 hasAuthorship W2109928541A5025632181 @default.
• W2109928541 hasAuthorship W2109928541A5036649021 @default.
• W2109928541 hasAuthorship W2109928541A5048394541 @default.
• W2109928541 hasAuthorship W2109928541A5084341919 @default.
• W2109928541 hasBestOaLocation W21099285411 @default.
• W2109928541 hasConcept C10936531 @default.
• W2109928541 hasConcept C126322002 @default.
• W2109928541 hasConcept C168563851 @default.
• W2109928541 hasConcept C177713679 @default.
• W2109928541 hasConcept C2778384902 @default.
• W2109928541 hasConcept C2781413609 @default.
• W2109928541 hasConcept C2987404301 @default.
• W2109928541 hasConcept C2993328841 @default.
• W2109928541 hasConcept C501593827 @default.
• W2109928541 hasConcept C535046627 @default.
• W2109928541 hasConcept C71924100 @default.
• W2109928541 hasConcept C86803240 @default.
• W2109928541 hasConcept C89423630 @default.
• W2109928541 hasConceptScore W2109928541C10936531 @default.
• W2109928541 hasConceptScore W2109928541C126322002 @default.
• W2109928541 hasConceptScore W2109928541C168563851 @default.
• W2109928541 hasConceptScore W2109928541C177713679 @default.
• W2109928541 hasConceptScore W2109928541C2778384902 @default.
• W2109928541 hasConceptScore W2109928541C2781413609 @default.
• W2109928541 hasConceptScore W2109928541C2987404301 @default.
• W2109928541 hasConceptScore W2109928541C2993328841 @default.
• W2109928541 hasConceptScore W2109928541C501593827 @default.
• W2109928541 hasConceptScore W2109928541C535046627 @default.
• W2109928541 hasConceptScore W2109928541C71924100 @default.
• W2109928541 hasConceptScore W2109928541C86803240 @default.
• W2109928541 hasConceptScore W2109928541C89423630 @default.
• W2109928541 hasIssue "3" @default.
• W2109928541 hasLocation W21099285411 @default.
• W2109928541 hasLocation W21099285412 @default.
• W2109928541 hasLocation W21099285413 @default.
• W2109928541 hasLocation W21099285414 @default.

• next